The FDA is granting full approval to a potential breakthrough Alzheimer's drug. Leqembi is the first drug proven to slow the memory-loss disease. Other approved drugs only target its symptoms. We spoke with one of the investigators behind the hefty clinical trial around this drug, Dr. Sharon Cohen,